JP Morgan Maintains Overweight on ESAB, Lowers Price Target to $95

Benzinga · 1d ago
JP Morgan analyst Tami Zakaria maintains ESAB (NYSE:ESAB) with a Overweight and lowers the price target from $125 to $95.